Work

Platelet-derived Growth Factor Inhibits Insulin Stimulation of Insulin Receptor Substrate-1-associated Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes without Affecting Glucose Transport

Year: 1998
Type: article
Abstract: Phosphatidylinositol 3-kinase (PI3K) activation is necessary for insulin-responsive glucose transporter (GLUT4) translocation and glucose transport. Insulin and platelet-derived growth factor (PDGF) stimulate PI3K activity in 3T3-L1 adipocytes, but only insulin is capable of stimulating GLUT4 translocation and glucose transport. We found that PDGF causes serine/threonine phosphorylation of insulin receptor substrate 1 (IRS-1) in 3T3-L1 cells, measured by altered mobility on SDS-polyacrylamide gel, and this leads to a decrease in insulin-stimulated tyrosine phosphorylation of IRS-1. The PI3K inhibitors wortmannin and LY294002 inhibit the PDGF-induced phosphorylation of IRS-1, whereas the MEK inhibitor PD98059 was without a major effect. PDGF pretreatment for 60–90 min led to a marked 80–90% reduction in insulin stimulatable phosphotyrosine and IRS-1-associated PI3K activity. We examined the functional consequences of this decrease in IRS-1-associated PI3K activity. Interestingly, insulin stimulation of GLUT4 translocation and glucose transport was unaffected by 60–90 min of PDGF preincubation. Furthermore, insulin activation of Akt and p70s6kinase, kinases downstream of PI3K, was unaffected by PDGF pretreatment. Wortmannin was capable of blocking these insulin actions following PDGF pretreatment, suggesting that PI3K was still necessary for these effects. In conclusion, 1) PDGF causes serine/threonine phosphorylation of IRS-1, and PI3K, or a kinase downstream of PI3K, mediates this phosphorylation. 2) This PDGF-induced phosphorylation of IRS-1 leads to a significant decrease in insulin-stimulated PI3K activity. 3) PDGF has no effect on insulin stimulation of Akt, p70s6kinase, GLUT4 translocation, or glucose transport. 4) This suggests the existence of an IRS-1-independent pathway leading to the activation of PI3K, Akt, and p70s6kinase; GLUT4 translocation; and glucose transport. Phosphatidylinositol 3-kinase (PI3K) activation is necessary for insulin-responsive glucose transporter (GLUT4) translocation and glucose transport. Insulin and platelet-derived growth factor (PDGF) stimulate PI3K activity in 3T3-L1 adipocytes, but only insulin is capable of stimulating GLUT4 translocation and glucose transport. We found that PDGF causes serine/threonine phosphorylation of insulin receptor substrate 1 (IRS-1) in 3T3-L1 cells, measured by altered mobility on SDS-polyacrylamide gel, and this leads to a decrease in insulin-stimulated tyrosine phosphorylation of IRS-1. The PI3K inhibitors wortmannin and LY294002 inhibit the PDGF-induced phosphorylation of IRS-1, whereas the MEK inhibitor PD98059 was without a major effect. PDGF pretreatment for 60–90 min led to a marked 80–90% reduction in insulin stimulatable phosphotyrosine and IRS-1-associated PI3K activity. We examined the functional consequences of this decrease in IRS-1-associated PI3K activity. Interestingly, insulin stimulation of GLUT4 translocation and glucose transport was unaffected by 60–90 min of PDGF preincubation. Furthermore, insulin activation of Akt and p70s6kinase, kinases downstream of PI3K, was unaffected by PDGF pretreatment. Wortmannin was capable of blocking these insulin actions following PDGF pretreatment, suggesting that PI3K was still necessary for these effects. In conclusion, 1) PDGF causes serine/threonine phosphorylation of IRS-1, and PI3K, or a kinase downstream of PI3K, mediates this phosphorylation. 2) This PDGF-induced phosphorylation of IRS-1 leads to a significant decrease in insulin-stimulated PI3K activity. 3) PDGF has no effect on insulin stimulation of Akt, p70s6kinase, GLUT4 translocation, or glucose transport. 4) This suggests the existence of an IRS-1-independent pathway leading to the activation of PI3K, Akt, and p70s6kinase; GLUT4 translocation; and glucose transport. epidermal growth factor insulin receptor substrate phosphatidylinositol 3-kinase platelet-derived growth factor microtubule-associated protein kinase insulin-responsive glucose transporter tumor necrosis factor α phosphotyrosine polyacrylamide gel electrophoresis phosphatidylinositol 3,4-bisphosphate phosphatidylinositol 3,4,5-trisphosphate adenosine triphosphate. Tyrosine kinase receptors such as the insulin receptor, the epidermal growth factor (EGF)1 receptor, and the platelet-derived growth factor (PDGF) receptor activate many of the same signaling cascades. The two most prominent shared pathways are the phosphatidylinositol 3-kinase (PI3K) and the microtubule-associated protein kinase (MAPK) pathways. Activation of MAPK leads to mitogenic progression and may be involved in differentiation (for review, see Ref. 1Seger R. Krebs E.G. FASEB J. 1995; 9: 726-735Crossref PubMed Scopus (3175) Google Scholar). Numerous studies using inhibitors of PI3K activity, expression of constitutively active PI3K, and microinjection of dominant negative inhibitors of PI3K have all demonstrated that PI3K is necessary for the mitogenic effects of many growth factors and is both necessary and sufficient for the metabolic effects of insulin (2Conricode K.M. Biochem. Mol. Biol. Int. 1995; 36: 835-843PubMed Google Scholar, 3Margalet-Sanchez V. Goldfine I.D. Vlahos C.J. Sung C.K. Biochem. Biophys. Res. Commun. 1994; 204: 446-452Crossref PubMed Scopus (122) Google Scholar, 4Okada T. Kawano Y. Sakakibara T. Hazeki O. Ui M. J. Biol. Chem. 1994; 269: 3568-3573Abstract Full Text PDF PubMed Google Scholar, 5Cheatham B. Vlahos C.J. Cheatham L. Wang L. Blenis J. Kahn C.R. Mol. Cell. Biol. 1994; 14: 4902-4911Crossref PubMed Scopus (996) Google Scholar, 6Berger J. Hayes N. Szalkowksi D.M. Zhang B. Biochem. Biophys. Res. Commun. 1994; 205: 570-576Crossref PubMed Scopus (36) Google Scholar, 7Clarke J.F. Young P.W. Yonezawa K. Kasuga M. Holman G.D. Biochem. J. 1994; 300: 631-635Crossref PubMed Scopus (330) Google Scholar). PI3K is composed of two subunits, an 85-kDa regulatory subunit (p85) and a 110-kDa catalytic subunit (p110). The p85 subunit is composed of an N-terminal Src-homology 3 (SH3) domain and 2 Src-homology 2 (SH2) domains. The SH2 domains flank the region where the p110 associates with p85. The SH2 domains interact with phosphotyrosine residues, leading to subsequent activation of the p110 catalytic subunit (for review, see Ref. 8Kapeller R. Cantley L.C. BioEssays. 1994; 16: 565-576Crossref PubMed Scopus (552) Google Scholar). Insulin stimulation leads to the tyrosine phosphorylation of insulin receptor substrates 1 and 2 (IRS-1/2) and the association of PI3K with the SH2 binding sites contained within these proteins. PDGF and EGF activate PI3K through its association with phosphotyrosines located in the C terminus of their receptors. PI3K exhibits both lipid and protein kinase activities. PI3K phosphorylates the D3 of the of the of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate R. Cantley L.C. BioEssays. 1994; 16: 565-576Crossref PubMed Scopus (552) Google Scholar). The of and the of PI3K, has a for and in the activation of an Akt kinase has T. PubMed Scopus Google Scholar). PI3K phosphorylates on serine/threonine R. O. Yonezawa K. Kasuga M. J. 1994; PubMed Scopus Google Scholar, K. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar, T. Y. Biochem. J. 1994; PubMed Scopus Google Scholar). The insulin receptor (IRS-1) is an in substrate for this activity K. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar, T. Y. Biochem. J. 1994; PubMed Scopus Google Scholar). 3T3-L1 a to the metabolic effects of insulin in a and EGF receptors. of these is capable of MAPK in these cells, but only insulin and PDGF activate PI3K J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar). the in insulin and PDGF receptor in these cells, PDGF and insulin activate PI3K to a the activation of PI3K has to be necessary for the metabolic effects of such as the translocation of the insulin-stimulated glucose to the glucose and has as to but causes translocation of GLUT4 and glucose transport both of these stimulation of PI3K (2Conricode K.M. Biochem. Mol. Biol. Int. 1995; 36: 835-843PubMed Google Scholar, 3Margalet-Sanchez V. Goldfine I.D. Vlahos C.J. Sung C.K. Biochem. Biophys. Res. Commun. 1994; 204: 446-452Crossref PubMed Scopus (122) Google Scholar, 4Okada T. Kawano Y. Sakakibara T. Hazeki O. Ui M. J. Biol. Chem. 1994; 269: 3568-3573Abstract Full Text PDF PubMed Google Scholar, 5Cheatham B. Vlahos C.J. Cheatham L. Wang L. Blenis J. Kahn C.R. Mol. Cell. Biol. 1994; 14: 4902-4911Crossref PubMed Scopus (996) Google Scholar, 6Berger J. Hayes N. Szalkowksi D.M. Zhang B. Biochem. Biophys. Res. Commun. 1994; 205: 570-576Crossref PubMed Scopus (36) Google Scholar, 7Clarke J.F. Young P.W. Yonezawa K. Kasuga M. Holman G.D. Biochem. J. 1994; 300: 631-635Crossref PubMed Scopus (330) Google Scholar). In this the insulin and PDGF signaling in 3T3-L1 Insulin and PDGF to of activation of PI3K, with insulin a activation of PI3K and PDGF effects. PDGF pretreatment the serine/threonine phosphorylation of IRS-1, with the of insulin to activate phosphorylation of of the major phosphorylation sites in IRS-1, may inhibit tyrosine phosphorylation of tyrosine a of K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). this of IRS-1-associated PI3K activity no effect on insulin of glucose GLUT4 translocation, or Akt and phosphorylation. effects of insulin are by PI3K that PI3K be the of insulin by an that whereas PI3K activity is necessary for the metabolic effects of IRS-1 phosphorylation is and and Insulin was a was and all LY294002 and PD98059 was Akt was and IRS-1 and and protein and The GLUT4 was was 3T3-L1 in by the with 1 and The was 2 and with and the of the differentiation the in or of and The was 80–90% of the lipid of 3T3-L1 with insulin or PDGF or with PDGF for and with insulin for in a 2 and for min with and or IRS-1 and protein by a with and with and and with C 1 and in C without the R. Cantley L.C. PubMed Scopus Google PI3K activity was by the phosphorylation of phosphatidylinositol in the of of the of by using the P.W. PubMed Scopus Google phosphatidylinositol was by of was to the in with or PDGF by insulin for the with wortmannin LY294002 or PD98059 for min to the of in the and for to IRS-1, or p85 to protein or was for to IRS-1 or p85 and protein in was to the and for by on or polyacrylamide to and with IRS-1, or to the with in the of by phosphorylation of IRS-1 was by a reduction in the mobility of IRS-1. 3T3-L1 adipocytes, with or without PDGF for min by min of insulin The translocation was as T. M. J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar). with in and with in a was with for for GLUT4 translocation an in The of for GLUT4 translocation was by glucose 3T3-L1 adipocytes, or with and 2 with or insulin for min or with or PDGF for or min or with PDGF for by min of insulin the and the was with was by the of of as J. Google Scholar). was by the of The was by and glucose was by with in 1 and was by for protein with insulin for min or with PDGF for or or with PDGF for or min by insulin for or with wortmannin and LY294002 for min to the of in the and for min of the with for and on a polyacrylamide by and to in with to Akt, or for and a was to the of the with and by Activation of PI3K by the tyrosine kinase receptors for and EGF has in 3T3-L1 adipocytes, only insulin and PDGF activate PI3K J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar). PI3K within min following stimulation the of activation for these two growth The PI3K activity by or was for to 3 and in PDGF-induced PI3K activity by min and was min stimulation 1 PI3K activity in IRS-1 was The of insulin to a activation of PI3K may to effects. We to the of PI3K activity following min of PDGF inhibit the of insulin to stimulate PI3K activity. We 3T3-L1 with PDGF for by min of insulin PI3K activity was with phosphotyrosine or IRS-1 PI3K activity was by with PDGF and was to by min of PDGF pretreatment 2 PI3K activity was by min of PDGF pretreatment, but min of PDGF insulin-stimulated PI3K to 2 these the of PI3K to with IRS-1 by and 3T3-L1 with insulin for PDGF for or or PDGF for min by insulin for PI3K was with by the with 2 in 2 insulin stimulation led to the association of PI3K with IRS-1 PDGF stimulation led to a association of PI3K with the PDGF receptor that was no following min of PDGF stimulation and of the for min with PDGF by min of insulin the association of PI3K with IRS-1 The of PDGF to inhibit insulin-stimulated PI3K may be to of the insulin pathway that leads to the activation of in 2 IRS-1, the major by insulin PI3K, is a for the PDGF effect. this 3T3-L1 with PDGF for by insulin stimulation for IRS-1 was with to the C terminus of IRS-1 3 or to phosphotyrosine 3 with a phosphotyrosine in 3 insulin tyrosine phosphorylation of IRS-1 and the insulin receptor subunit 3 whereas PDGF led to tyrosine phosphorylation of the PDGF receptor and a 3 with of PDGF pretreatment, tyrosine phosphorylation of IRS-1 was and min of PDGF pretreatment, IRS-1 phosphorylation was by 3 Interestingly, PDGF-induced of the PDGF receptor was to by 3 3T3-L1 with insulin for min following PDGF stimulation for IRS-1 was following with an IRS-1 The same was for in 3 an IRS-1 gel following PDGF stimulation and was within min of PDGF 3 the of IRS-1 tyrosine phosphorylation was by a mobility of IRS-1, or phosphorylation K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). is to that whereas PDGF IRS-1 tyrosine phosphorylation 3 IRS-1 expression was by PDGF pretreatment 3 PDGF both the PI3K and MAPK pathways in 3T3-L1 J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar). the that PI3K, or downstream of these pathways for the serine/threonine phosphorylation of IRS-1. We the PI3K inhibitors wortmannin and LY294002 and the MEK inhibitor PD98059 to of these is in 3 pretreatment with LY294002 or wortmannin the PDGF-induced IRS-1 gel with PD98059 a of the IRS-1 gel K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google but the effect was as as that with the PI3K inhibitors 3 that PI3K or a protein downstream of PI3K is involved in the serine/threonine phosphorylation of IRS-1 but that MAPK a major This is with that PI3K phosphorylates IRS-1 on in K. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar, T. Y. Biochem. J. 1994; PubMed Scopus Google Scholar). The serine/threonine phosphorylation and decrease in tyrosine phosphorylation of IRS-1 may in to the association of PI3K with IRS-1. has that activation of PI3K is a necessary for insulin-stimulated GLUT4 translocation Holman G.D. Biochem. J. PubMed Scopus Google and is that PI3K is sufficient for this effect B. Vlahos C.J. Cheatham L. Wang L. Blenis J. Kahn C.R. Mol. Cell. Biol. 1994; 14: 4902-4911Crossref PubMed Scopus (996) Google Scholar, 7Clarke J.F. Young P.W. Yonezawa K. Kasuga M. Holman G.D. Biochem. J. 1994; 300: 631-635Crossref PubMed Scopus (330) Google Scholar). PDGF pretreatment has a major effect on insulin-stimulated PI3K activity, the of PDGF on insulin-stimulated glucose transport. 3T3-L1 with insulin or PDGF or with PDGF for by insulin in insulin a in glucose whereas PDGF only a effect. of with PDGF for to min inhibit insulin-stimulated glucose transport. This is in to the marked effect of PDGF pretreatment to inhibit insulin-stimulated or PI3K activity. In the insulin was a and that an effect of PDGF pretreatment be insulin insulin studies in 3T3-L1 adipocytes, with and without PDGF pretreatment. demonstrated in a PDGF pretreatment no effect on glucose transport the insulin The of PDGF to inhibit insulin-stimulated glucose its marked effect on insulin-stimulated PI3K activity, that PI3K activation is for glucose transport In the PI3K inhibitor wortmannin was insulin-stimulated glucose transport with and without PDGF In measured GLUT4 insulin and and GLUT4 translocation was with using and T. M. J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar, T. M. PubMed Scopus Google Scholar). The of a the that a is for GLUT4 translocation, whereas is as negative T. M. J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar, T. M. PubMed Scopus Google Scholar). The of these are in that PDGF pretreatment inhibit the subsequent effect of insulin to stimulate GLUT4 Furthermore, PDGF stimulate translocation Y. J. Biochem. PubMed Scopus Google is that the effect of PDGF to glucose transport stimulation of has that the activation of Akt kinase a serine/threonine kinase downstream of PI3K, is necessary for metabolic effects of GLUT4 translocation, glucose and to the effect of PDGF pretreatment on insulin-stimulated Akt activity in the 3T3-L1 with insulin or PDGF or with PDGF for by insulin by by with an or an the gel mobility serine/threonine phosphorylation and activation of The is and activation of Akt min of insulin stimulation led to a significant in Akt activation as with the or by gel with the Akt PDGF Akt, but to the same as insulin of the with PDGF for or min no effect on the of a subsequent of insulin to stimulate Akt activation The activation of Akt, with or without PDGF was by with wortmannin and that PI3K is necessary for Akt has that is downstream of PI3K and Akt and that activation of PI3K Akt is necessary for stimulation 1995; PubMed Scopus Google Scholar). the effect of PDGF pretreatment on this with insulin or PDGF or with PDGF by insulin The by with a The of these studies are in and are to for Akt insulin led to an in and the effect of insulin was that of only a and effect. PDGF pretreatment no on subsequent insulin stimulation of the effect of PDGF to the of insulin to stimulate PI3K activity, Akt activation was The of the signaling pathway leading PI3K to Akt and may insulin-stimulated GLUT4 translocation and glucose unaffected by PDGF pretreatment. We and have that PI3K activity, as as of this are necessary for insulin-stimulated glucose transport (2Conricode K.M. Biochem. Mol. Biol. Int. 1995; 36: 835-843PubMed Google Scholar, 3Margalet-Sanchez V. Goldfine I.D. Vlahos C.J. Sung C.K. Biochem. Biophys. Res. Commun. 1994; 204: 446-452Crossref PubMed Scopus (122) Google Scholar, 4Okada T. Kawano Y. Sakakibara T. Hazeki O. Ui M. J. Biol. Chem. 1994; 269: 3568-3573Abstract Full Text PDF PubMed Google Scholar, 5Cheatham B. Vlahos C.J. Cheatham L. Wang L. Blenis J. Kahn C.R. Mol. Cell. Biol. 1994; 14: 4902-4911Crossref PubMed Scopus (996) Google Scholar, 6Berger J. Hayes N. Szalkowksi D.M. Zhang B. Biochem. Biophys. Res. Commun. 1994; 205: 570-576Crossref PubMed Scopus (36) Google Scholar, 7Clarke J.F. Young P.W. Yonezawa K. Kasuga M. Holman G.D. Biochem. J. 1994; 300: 631-635Crossref PubMed Scopus (330) Google Scholar, K. Biochem. J. PubMed Scopus Google Scholar, K. Mol. Cell. Biol. PubMed Scopus Google Scholar). PDGF stimulate PI3K activity in 3T3-L1 but to stimulation of glucose transport (2Conricode K.M. Biochem. Mol. Biol. Int. 1995; 36: 835-843PubMed Google Scholar, 3Margalet-Sanchez V. Goldfine I.D. Vlahos C.J. Sung C.K. Biochem. Biophys. Res. Commun. 1994; 204: 446-452Crossref PubMed Scopus (122) Google Scholar, 4Okada T. Kawano Y. Sakakibara T. Hazeki O. Ui M. J. Biol. Chem. 1994; 269: 3568-3573Abstract Full Text PDF PubMed Google Scholar). In PDGF to serine/threonine phosphorylation of IRS-1 Y. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). In the have of these to the of PDGF on the insulin-stimulated glucose transport. The major of these are that PDGF serine/threonine phosphorylation of IRS-1, as measured by altered mobility on a SDS-polyacrylamide This effect of PDGF is by with that the p110 subunit of PI3K is for IRS-1 phosphorylation. We that this serine/threonine phosphorylation of IRS-1 leads to a marked decrease in the of IRS-1 to with PI3K following insulin this marked decrease in insulin-stimulated IRS-1-associated PI3K activity to of downstream signaling effects of such as stimulation of GLUT4 translocation, glucose and Akt and phosphorylation. to and Insulin leads to tyrosine phosphorylation of IRS-1, association with the SH2 domains of the p85 subunit of PI3K, leading to stimulation of PI3K activity M. B. J. J. PubMed Scopus Google Scholar). IRS-1 be in by the p110 subunit K. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar, T. Y. Biochem. J. 1994; PubMed Scopus Google as as MAPK K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google and in tumor necrosis factor α R. PubMed Scopus Google and PDGF Y. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google serine/threonine phosphorylation of IRS-1. phosphorylation of IRS-1 has to its tyrosine phosphorylation by the insulin receptor R. PubMed Scopus Google IRS-1 association with PI3K and subsequent PI3K activity J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). We the functional consequences of these effects. We found that PDGF of 3T3-L1 led to serine/threonine phosphorylation of IRS-1, as by mobility on SDS-polyacrylamide This effect of PDGF be by with the PI3K inhibitors wortmannin and but is by with the MEK inhibitor that such as IRS-1 in K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google in following stimulation with PDGF is by the p110 subunit of PI3K or a serine/threonine kinase downstream of PI3K activity. the functional consequences of PDGF-induced IRS-1 serine/threonine phosphorylation. We found that with PDGF a decrease in insulin-stimulated IRS-1 tyrosine phosphorylation and a marked in the of IRS-1 to with PI3K following insulin that with PDGF an 80–90% decrease in insulin stimulatable PI3K activity, with or IRS-1 This a PDGF-induced of IRS-1 PI3K binding to IRS-1. K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google demonstrated that the phosphorylation of IRS-1 on causes a in IRS-1 tyrosine phosphorylation of tyrosine a of The PDGF-induced of IRS-1-associated PI3K activity was the reduction in insulin-stimulated IRS-1 tyrosine that the phosphotyrosines involved in PI3K association to a IRS-1 phosphorylation or that such as a in to tyrosine is for the in this of insulin-stimulated IRS-1-associated PI3K activity no on the downstream insulin signaling that is that insulin stimulation of GLUT4 translocation and glucose transport is (2Conricode K.M. Biochem. Mol. Biol. Int. 1995; 36: 835-843PubMed Google Scholar, 3Margalet-Sanchez V. Goldfine I.D. Vlahos C.J. Sung C.K. Biochem. Biophys. Res. Commun. 1994; 204: 446-452Crossref PubMed Scopus (122) Google Scholar, 4Okada T. Kawano Y. Sakakibara T. Hazeki O. Ui M. J. Biol. Chem. 1994; 269: 3568-3573Abstract Full Text PDF PubMed Google Scholar, 5Cheatham B. Vlahos C.J. Cheatham L. Wang L. Blenis J. Kahn C.R. Mol. Cell. Biol. 1994; 14: 4902-4911Crossref PubMed Scopus (996) Google Scholar, 6Berger J. Hayes N. Szalkowksi D.M. Zhang B. Biochem. Biophys. Res. Commun. 1994; 205: 570-576Crossref PubMed Scopus (36) Google Scholar, 7Clarke J.F. Young P.W. Yonezawa K. Kasuga M. Holman G.D. Biochem. J. 1994; 300: 631-635Crossref PubMed Scopus (330) Google but PDGF pretreatment no effect on the subsequent of insulin to stimulate translocation of GLUT4 to the or glucose transport activity. the with PDGF pretreatment, insulin stimulation of GLUT4 translocation and glucose transport activity was still by wortmannin and This that these effects of insulin on PI3K activity and the that a such as that by or M. K. M. M. Kasuga M. Mol. PubMed Scopus Google Scholar, J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google is for the insulin effect the of PDGF pretreatment. that PDGF insulin-stimulated IRS-1-associated PI3K activity but the of insulin to stimulate glucose glucose transport In these the of IRS-1 stimulation of glucose transport. are for these The is that insulin stimulation of IRS-1 tyrosine with its subsequent binding to and activation of PI3K, is for the of insulin to stimulate glucose transport. is that insulin glucose transport by two may be or of these pathways IRS-1, the of this is by the In this the pathway PI3K that all insulin stimulation of glucose transport is is that only a of IRS-1-associated PI3K is necessary for stimulation of glucose transport. only a of IRS-1-associated PI3K activity PDGF pretreatment, is that this of activity, is to a transport this the to an of transport insulin In the for insulin-stimulated glucose transport be to the This is the in the of PDGF pretreatment, a of insulin to a of IRS-1-associated PI3K activity a of insulin of PDGF in PDGF no effect on the transport the that a of PI3K activity glucose transport to be in a and that the the leading to a The on the of IRS-1 in insulin-stimulated glucose transport is studies for a significant whereas are with the that IRS-1 only a in this effect of IRS-1 marked growth but are only insulin and are M. and L. Scholar, B. Kahn C.R. 1994; PubMed Scopus Google Scholar, T. K. K. Y. R. Y. Y. N. Y. T. Mol. Cell. Biol. 16: PubMed Scopus Google Scholar, Y. R. K. K. T. Y. Y. T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). are with the with to metabolic or pathways Furthermore, IRS-1 glucose transport M. and L. or a decrease in glucose transport B. Kahn C.R. 1994; PubMed Scopus Google Scholar, T. K. K. Y. R. Y. Y. N. Y. T. Mol. Cell. Biol. 16: PubMed Scopus Google Scholar, Y. R. K. K. T. Y. Y. T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, J. Biol. Chem. Full Text PDF PubMed Google a of IRS-1 In studies using IRS-1 or these M. and L. Scholar, B. Kahn C.R. 1994; PubMed Scopus Google has that for the of IRS-1 activity, this is the in all studies Y. R. K. K. T. Y. Y. T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). This is to an for PI3K activity have in the is to that in IRS-1 in IRS-1 is and is only a reduction in insulin-stimulated glucose transport is with no in insulin as by the insulin these Y. R. K. K. T. Y. Y. T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google that an but pathway that this pathway Y. R. K. K. T. Y. Y. T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). signaling through is to be in 3T3-L1 Y. R. K. K. T. Y. Y. T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google and Interestingly, IRS-1 was with an J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google a in the was whereas no in In in IRS-1 a decrease in was with no in the B. Kahn C.R. 1994; PubMed Scopus Google Scholar). in the receptor and GLUT4 in that stimulation with no effect on glucose the that tyrosine phosphorylation of IRS-1 and its association with PI3K J. 1995; PubMed Scopus Google Scholar). K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google have that the expression in of two insulin receptor IRS-1 phosphorylation but to stimulate the studies by J. 1995; PubMed Scopus Google and K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google are both that IRS-1 with PI3K is sufficient to metabolic that an metabolic is In T. M. PubMed Scopus Google IRS-1 and 3T3-L1 and found no effect on insulin-stimulated GLUT4 translocation, the that insulin such as and by these K. Mol. Cell. Biol. PubMed Scopus Google an to the IRS-1 and domains in 3T3-L1 domains as inhibitors of insulin leading to a IRS-1 phosphorylation and IRS-1-associated PI3K activity. this of insulin-stimulated Akt GLUT4 translocation, and glucose transport in or 3T3-L1 K. Mol. Cell. Biol. PubMed Scopus Google Scholar). the of these examined of insulin that are to be downstream of Akt, a serine/threonine kinase downstream of PI3K, is following insulin or PDGF stimulation 1995; PubMed Scopus Google Scholar). Akt is by a the binding of to the Akt domain T. PubMed Scopus Google as as serine/threonine phosphorylation by or Akt may be by the lipid of PI3K T. PubMed Scopus Google Scholar). Furthermore, that activation of Akt may be necessary for GLUT4 translocation T. Y. PubMed Google Scholar, J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The expression of a constitutively active Akt in T. Y. PubMed Google or 3T3-L1 J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google GLUT4 translocation and glucose with these that PDGF pretreatment of the of insulin to activate the that insulin-stimulated IRS-1-associated PI3K activity is by PDGF pretreatment, the effect of insulin to stimulate Akt in the of PDGF is still by wortmannin and that Akt activation is on a for Akt as a of GLUT4 phosphorylation was unaffected by PDGF pretreatment, that the pathway PI3K to was still that an pathway for PI3K is of and that this pathway is sufficient to activate Akt and p70s6kinase, as as stimulate glucose transport. has that the of but to stimulate GLUT4 translocation is to of PI3K following insulin Insulin stimulation leads to the of PI3K activity to the and whereas PDGF stimulation only in PI3K activity in the Y. J. Biochem. PubMed Scopus Google Scholar, K. Biochem. J. PubMed Scopus Google Scholar). are with this but that a pathway or in IRS-1, is capable of this of PI3K, such that PI3K in this stimulate Akt GLUT4 translocation, and glucose transport. We the existence of insulin-stimulated protein that with and PI3K of IRS-1. has to for IRS-1 in expression of IRS-1 is M. and L. Scholar, B. Kahn C.R. 1994; PubMed Scopus Google Scholar). phosphotyrosine activity, this is an for PI3K may be capable of with insulin receptor such as or insulin receptor and receptors may be an for The of activate a PI3K that is J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google and leads to Akt activation B. M. M. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). are necessary to the of insulin-stimulated PI3K activity following PDGF
Language: English
Open Access status: hybrid
Estimated APC paid: $3,430
OpenAlex ID: W2045726368
FWCI: 3.566
Cites: 41
Cited by: 89
Related to: 10